Fresh Off Schering-Plough Deal, Huya Signs Pact With Beijing Institute To Open Bridge To Global Markets
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Huya Bioscience International has signed a partnership agreement with the Beijing Institute of Materia Medica on joint development of innovative drugs that ultimately could help the institute penetrate the American and European markets, according to a senior Huya executive
You may also be interested in...
San Diego's Huya Signs Six New Deals With Chinese Scientific Partners, Looks To Fast Forward Global Drug Development
BEIJING - During a whirlwind tour of China, the leaders of the San Diego-headquartered Huya Bioscience have signed, in rapid succession, partnership pacts with prestigious scientific institutions in half a dozen cities on drug research and development
San Diego's Huya Signs Six New Deals With Chinese Scientific Partners, Looks To Fast Forward Global Drug Development
BEIJING - During a whirlwind tour of China, the leaders of the San Diego-headquartered Huya Bioscience have signed, in rapid succession, partnership pacts with prestigious scientific institutions in half a dozen cities on drug research and development
China On The Road Toward Becoming World Center For Drug Innovation, Say Huya Bioscience Leaders
BEIJING - The science-savvy leaders of China, along with the Western-educated Chinese chemists and biologists migrating back here, are helping lay the foundation for the country one day to become a world center for innovation in developing new-generation medicines, according to senior executives at the San Diego-headquartered Huya Bioscience